Fundraising Fox

Link Immunotherapeutics

Seattle, US · Founded 2019 · Delaware corporation · 3 employees on LinkedIn · 1 known investors

Founders & leadership

MD
Meininger DavidNamed on SEC filing

Board

RURoger Ulrich
Roger UlrichBoard directorSenior Advisor at BioGeneration Ventures
EVEdward van Wezel
Edward van WezelinBoard directorManaging Partner at BioGeneration Ventures
DO
Daniel O'ConnellBoard director

Investors · 1

BioGeneration VenturesreportedNaardenvia Edward van Wezel · board

Reported raises · per SEC filings

Form D private placements

$14.3M disclosed across 1 round · 2021

▶$14.3MraisedApr 2021 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel O'ConnellDirector
  • Meininger DavidExecutive Officer, Director, Promoter
  • Roger UlrichDirector
  • Edward van WezelDirector
Offering amount
$17.3M
Amount sold
$14.3M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Link Immunotherapeutics's investors?
Link Immunotherapeutics's investors include BioGeneration Ventures.
How much funding has Link Immunotherapeutics raised?
Link Immunotherapeutics has disclosed $14.3M raised across 1 round.
Where is Link Immunotherapeutics headquartered?
Link Immunotherapeutics is headquartered in Seattle, US.